ReviewJournal of veterinary science2024
Awareness on the spread of carbapenem-resistant Enterobacterales in animals as One Health.
Review in Journal of veterinary science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Carbapenemases: epidemiology, detection and management in a changing global landscape.JAC-antimicrobial resistance · 2026Review
- Role of Mobilome in Carbapenem Resistance.Antibiotics (Basel, Switzerland) · 2026Review
- Insights from the WHO Tricycle-aligned Fleming Fund EQASIA External Quality Assessment (EQA) programme detecting ESBL-, AmpC- and carbapenemase-producing Escherichia coli in South and South-East Asia.The Journal of antimicrobial chemotherapy · 2026Article
- Limited detection of carbapenem-resistant Enterobacterales in veterinary patients at a Canadian referral hospital.The Canadian veterinary journal = La revue veterinaire canadienne · 2026Article
- Management of carbapenem-resistant Enterobacterales in a veterinary hospital environment utilizing surveillance with infection control and prevention measures.Journal of veterinary internal medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
One Health is a multisectoral cooperative and collaborative approach aimed at achieving integrated health by recognizing the interconnectedness of people, animals, plants, and the environment. In the modern world, the One Health approach is considered an essential perspective for overcoming various emerging diseases, including antimicrobial resistance (AMR). One of the top priority AMR infections is caused by carbapenem-resistant Enterobacterales (CRE), which are bacterial strains not susceptible to carbapenems, the last-resort antibiotics for clinical Gram-negative bacterial infections. Although carbapenems are not allowed to use in animals in the global community, various types of CRE are being reported among animals, including the carbapenemase-producing Enterobacterales (CPE). Therefore, since the dissemination and clinical infection of CPE represent a shared health threat, measures to raise awareness of this issue should be considered from the perspective of the One Health approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.